GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioArctic AB (STU:B9A) » Definitions » 3-Year Dividend Growth Rate

BioArctic AB (STU:B9A) 3-Year Dividend Growth Rate : 0.00% (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is BioArctic AB 3-Year Dividend Growth Rate?

BioArctic AB's Dividends per Share for the three months ended in Mar. 2024 was €0.00.

The historical rank and industry rank for BioArctic AB's 3-Year Dividend Growth Rate or its related term are showing as below:

STU:B9A's 3-Year Dividend Growth Rate is not ranked *
in the Biotechnology industry.
Industry Median: 14.15
* Ranked among companies with meaningful 3-Year Dividend Growth Rate only.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

BioArctic AB's Dividend Payout Ratio for the three months ended in Mar. 2024 was 0.00. As of today, BioArctic AB's Dividend Yield % is 0.00%.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of BioArctic AB's 3-Year Dividend Growth Rate

For the Biotechnology subindustry, BioArctic AB's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioArctic AB's 3-Year Dividend Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioArctic AB's 3-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where BioArctic AB's 3-Year Dividend Growth Rate falls into.



BioArctic AB 3-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


BioArctic AB  (STU:B9A) 3-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

BioArctic AB's Dividend Payout Ratio for the quarter that ended in Mar. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Mar. 2024 )/ EPS without NRI (Q: Mar. 2024 )
=0/ -0.057
=N/A

During the past 9 years, the highest Dividend Payout Ratio of BioArctic AB was 1.50. The lowest was 1.50. And the median was 1.50.

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

During the past 9 years, the highest Dividend Yield of BioArctic AB was 2.91%. The lowest was 1.49%. And the median was 2.10%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioArctic AB 3-Year Dividend Growth Rate Related Terms>


BioArctic AB (STU:B9A) Business Description

Industry
Traded in Other Exchanges
Address
Warfvinges vag 35, Stockholm, SWE, SE-112 51
BioArctic AB is a research-based biopharmaceutical company focusing on disease-modifying treatments and diagnostics for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, and ALS. In addition, the group is also focused on the development of a treatment with a combination of a biodegradable medical device and a drug substance for complete spinal cord injury. Geographically, it derives a majority of its revenue from Asia.

BioArctic AB (STU:B9A) Headlines

No Headlines